Enterprise Value
11.56M
Cash
19.68M
Avg Qtr Burn
-3.572M
Short % of Float
0.00%
Insider Ownership
3.35%
Institutional Own.
30.17%
Qtr Updated
12/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SG016 / SNG001 Details COVID-19 | Phase 3 Data readout | |
IFN-β (SNG001) Details Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 Data readout |